Parallel trade in medicinal drugs is putting the welfare of EU patients at risk

Costa-i-Font, Joan ORCID: 0000-0001-7174-7919 (2015) Parallel trade in medicinal drugs is putting the welfare of EU patients at risk. LSE European Politics and Policy (EUROPP) Blog (20 Mar 2015). Website.

Preview

PDF Download (87kB) | Preview

• Publisher
• Author

Abstract

The term ‘parallel trade’ refers to instances in which a product sold for a low price in one country is bought and transported to a second country in which the same product sells for a higher price, allowing for a profit to be made. Joan Costa-i-Font writes that the EU’s single market has helped facilitate this practice in Europe with respect to the trade in medicinal drugs. He notes that one of the potential dangers of parallel trade is that shortages of certain drugs could develop in countries where prices are low due to companies buying up products and exporting them to more expensive markets.

Item Type:	Online resource (Website)
Official URL:	http://blogs.lse.ac.uk/europpblog/
Additional Information:	© 2015 The Author(s)
Divisions:	LSE
Subjects:	J Political Science > JN Political institutions (Europe) R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Date Deposited:	29 Mar 2017 11:04
Last Modified:	01 Nov 2024 04:06
URI:	http://eprints.lse.ac.uk/id/eprint/71376

Actions (login required)

View Item